Susan Guo

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate

Samir K. Gupta, Frank A. Post, José Ramón Arribas et al. · AIDS · 2019 · 160 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results

José Ramón Arribas, Melanie Thompson, Paul E. Sax et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2017 · 116 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy

Devi SenGupta, Cynthia Brinson, Edwin DeJesus et al. · Science Translational Medicine · 2021 · 78 citations

Life Sciences, Infectious Diseases, Pharmacology +15

Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus–1

Sharon A. Riddler, Michael F. Para, Constance A. Benson et al. · Clinical Infectious Diseases · 2020 · 74 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience

Susan Guo, C.A. Reddy, M.D. Kolar et al. · Radiation Oncology · 2012 · 51 citations · Full text

Medicine, Radiation Oncology, Surgery +14